Skip to main content

Medical Association Guidelines, Post-2002/Women’s Health Initiative Findings

  • Chapter
  • First Online:
  • 1447 Accesses

Abstract

The findings of the NIH’s Women’s Health Initiative Study in 2002 changed forever the way that HT had been understood to work and the wide range of benefits it was thought to have provided. In the decade since, researchers and practitioners have come to understand safer ways to prescribe estrogen and estrogen plus progesterone replacement therapy so that women seeking relief from menopause symptoms can access a safe hormone therapy that relieves symptoms without suffering from unwanted and dangerous side effects.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Bibliography

  1. ACOG Committee on Gynecologic Practice. Committee opinion number 322, November 2005. Compounded bioidentical hormones. Obstet Gynecol 2005;106(5 part 1): 1139–40.

    Google Scholar 

  2. North American Menopause Society. Position statement: Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause. 2010;17(2):242–55.

    Article  Google Scholar 

  3. Santen RJ, Allred DC, Ardoin SP, et al. Executive summary: postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab. 2010;95 suppl 1:S1–66.

    Article  PubMed  CAS  Google Scholar 

  4. Sturdee DW, Pines A, International Menopause Society Writing Group, et al. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric 2011;14:302–20.

    Google Scholar 

  5. Sturdee DW, Pines A, on behalf of the International Menopause Society Writing Group. Updated IMS recommendations on postmenopausal hormone therapy and preventive strategies for midlife health. Climacteric 2011;14:302–20.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Sherif, K. (2013). Medical Association Guidelines, Post-2002/Women’s Health Initiative Findings. In: Hormone Therapy. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6268-2_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-6268-2_3

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-6267-5

  • Online ISBN: 978-1-4614-6268-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics